Sally Beauty's Q3 earnings beat as margin gains offset weak sales, but tighter 2026 guidance keeps demand concerns in focus.

Sally Beauty looks cheap compared with its peers, but BSG weakness and slow sales growth make margin gains and e-commerce key to the buy case.

SBH's 34.3% rally is backed by digital growth and margin gains, but BSG weakness and a higher historical multiple could limit upside.

ELF raises its fiscal 2027 outlook as Rhode outperforms expectations, international sales surge and global expansion adds growth runway.

ELF's faster portfolio growth, Rhode momentum and raised fiscal 2027 outlook strengthen its case, but premium valuation and core-brand softness raise execution risks.

ELF's 18.8% weekly surge is backed by Rhode growth, stronger guidance and global expansion, though core softness and a premium valuation raise execution stakes.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

e.l.f. Beauty tops Q1 estimates as Rhode delivers $160 million in sales, international revenues jump 61%, and fiscal 2027 guidance is raised.

e.l.f. Beauty raises its fiscal 2027 outlook as rhode demand, improving organic trends and global expansion drive 36% of first-quarter sales growth.

e.l.f. Beauty (ELF) delivered earnings and revenue surprises of +146.48% and +12.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?